Charles Hyde

Charles Hyde is a Market Access Leader with extensive experience in the pharmaceutical industry, specializing in small molecule and specialty pharmaceuticals. They held various roles at companies such as Marion Merrell Dow and Merrell Dow before advancing to significant positions at Sanofi and Lexicon Pharmaceuticals, where they successfully launched a rare disease drug into the oncology space. Currently, Charles serves as the Head of Market Access at Sera Prognostics, leading coding, coverage, and reimbursement functions for the payer channel. They earned a Bachelor's Degree in Biology and Chemistry from Hope College and an MBA from Saint Joseph's University.